About the Authors
- Gaston De Serres
-
Contributed equally to this work with: Gaston De Serres, Danuta M. Skowronski
* E-mail: gaston.deserres@inspq.qc.ca
Affiliations Institut national de santé publique du Québec, Quebec City, Quebec, Canada, Laval University, Quebec City, Quebec, Canada
- Danuta M. Skowronski
-
Contributed equally to this work with: Gaston De Serres, Danuta M. Skowronski
Affiliations British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada, University of British Columbia, Vancouver, British Columbia, Canada
- Brian J. Ward
-
Affiliation Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
- Michael Gardam
-
Affiliation University of Toronto, University Health Network, Toronto, Ontario, Canada
- Camille Lemieux
-
Affiliation University of Toronto, University Health Network, Toronto, Ontario, Canada
- Annalee Yassi
-
Affiliation University of British Columbia, Vancouver, British Columbia, Canada
- David M. Patrick
-
Affiliations British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada, University of British Columbia, Vancouver, British Columbia, Canada
- Mel Krajden
-
Affiliations British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada, University of British Columbia, Vancouver, British Columbia, Canada
- Mark Loeb
-
Affiliation McMaster University, Faculty of Health Sciences, Hamilton, Ontario, Canada
- Peter Collignon
-
Affiliations Australian National University, Acton, Australia, Canberra Hospital, Garran, ACT, Australia
- Fabrice Carrat
-
Affiliations Institut National de la Santé et de la Recherche Médicale, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France, Sorbonne Universités, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Unité de Santé Publique, Paris, France
Competing Interests
GDS, MG, CL and AY have been engaged (with or without remuneration) to provide expert testimony during legal challenges against enforced healthcare workers influenza vaccination policies in Canada. GDS has received grants from GSK and Pfeizer and travel reimbursement to attend an ad hoc advisory board meeting of GSK. BJW has participated in clinical trials and ad hoc advisory boards with several vaccine manufacturers as well as receiving occasional speaker's fees. He has held or holds research grants with GSK and Medicago. He is medical officer for Medicago Inc. and has served as an expert witness for US and Quebec vaccine injury compensation programs. MK has received research grants from Roche, Merck, Siemens, Hologic, and Boerhinger Ingelheim for unrelated studies. FC has received personal fees from AstraZeneca and GlaxoSmithKline for consultancy on influenza epidemiology outside the submitted work. DMS, DMP, ML and PC have no competing interests to report. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: GDS DMS. Data curation: GDS DMS. Formal analysis: GDS DMS. Funding acquisition: GDS. Investigation: GDS DMS. Methodology: GDS DMS. Project administration: GDS DMS. Resources: GDS DMS. Supervision: GDS DMS. Validation: GDS DMS BJW MG CL AY DP MK ML PC FC. Visualization: GDS DMS. Writing – original draft: GDS DMS. Writing – review & editing: GDS DMS BJW MG CL AY DP MK ML PC FC.